CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-19 | FREEMAN KEVIN D Director | Purchase | +5,000 | $1.96 | $10K | 50,000 |
| 2022-01-14 | Zordani Richard A. Jr. Director | Purchase | +5,000 | $2.02 | $10K | 19,583 |
| 2022-01-14 | LEWIS JOEL President and CEO | Grant or award | +8,251 | $2.02 | $17K | 307,868 |
| 2021-12-20 | Uihlein Richard E Director | Grant or award · Convertible Note | +1,841,621 | $10,000,000.00 | $18416.2B | 10,000,000 |
Page 21 of 21 · 404 trades